Literature DB >> 7843218

Interleukin-12 production by human polymorphonuclear leukocytes.

M A Cassatella1, L Meda, S Gasperini, A D'Andrea, X Ma, G Trinchieri.   

Abstract

Human polymorphonuclear leukocytes (PMN) stimulated by lipopolysaccharide (LPS) produce interleukin-12 (IL-12). Both the free IL-12 p40 chain and minute amounts of the biologically active IL-12 p70 heterodimers are produced by PMN. Interferon-gamma (IFN-gamma) enhanced the LPS-induced secretion of both the free IL-12 p40 chain and the p70 heterodimer by approximately fivefold. As observed for other IL-12-producing cell types, the ratio of free p40 chain to p70 heterodimer secreted by LPS-stimulated PMN was approximately 20:1. LPS induced a 100-fold increase of IL-12 p40 mRNA, but had minimal effect on p35 mRNA accumulation. IFN-gamma enhanced the LPS-induced accumulation of p40 mRNA and directly induced a several-fold increase in the accumulation of p35 mRNA. Therefore, the combined effect of LPS and IFN-gamma induced sufficient expression of both p40 and p35 to attain production of the biologically active p70 heterodimer at physiologically relevant concentrations. The ratio between p40 and p35 mRNA abundance in PMN stimulated with both LPS and IFN-gamma was approximately 200:1, explaining the secretion of the free p40 chain in much higher concentrations than the p70 heterodimer. IL-10, an inhibitor of the production of various cytokines in PMN, also suppressed IL-12 mRNA accumulation and secretion by PMN. Because of the important immunoregulatory function of IL-12, in particular induction of IFN-gamma production and facilitation of T helper cell type 1 response, the ability of PMN to produce IL-12 suggests that neutrophils may play an active role in the regulatory interaction between innate resistance and adaptive immunity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7843218     DOI: 10.1002/eji.1830250102

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  53 in total

Review 1.  IL-12 as a therapeutic target for pharmacological modulation in immune-mediated and inflammatory diseases: regulation of T helper 1/T helper 2 responses.

Authors:  G Haskó; C Szabó
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

2.  Role of polymorphonuclear neutrophils in a murine model of Chlamydia psittaci-induced abortion.

Authors:  A J Buendía; R M De Oca; J A Navarro; J Sánchez; F Cuello; J Salinas
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Interleukin-12 alone can not enhance the expression of the cutaneous lymphocyte associated antigen (CLA) by superantigen-stimulated T lymphocytes.

Authors:  H Sigmundsdóttir; J E Gudjónsson; H Valdimarsson
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

Review 4.  The role of gamma/delta T cells in immunity to infection and regulation of inflammation.

Authors:  H Kirk Ziegler
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

5.  Differential expression of the cytokine receptors for human interleukin (IL)-12 and IL-18 on lymphocytes of both CD45RA and CD45RO phenotype from tonsils, cord and adult peripheral blood.

Authors:  M Bofill; E Almirall; A McQuaid; R Peña; R Ruiz-Hernandez; M Naranjo; L Ruiz; B Clotet; F E Borràs
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

6.  Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis.

Authors:  S A Fulton; J M Johnsen; S F Wolf; D S Sieburth; W H Boom
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

7.  Neutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of mice.

Authors:  J Pedrosa; B M Saunders; R Appelberg; I M Orme; M T Silva; A M Cooper
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

8.  CD46-utilizing adenoviruses inhibit C/EBPbeta-dependent expression of proinflammatory cytokines.

Authors:  Milena Iacobelli-Martinez; Ronald R Nepomuceno; Jodi Connolly; Glen R Nemerow
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Redirecting adaptive immunity against foreign antigens to tumors for cancer therapy.

Authors:  Wenxian Hu; John J Davis; Hongbo Zhu; Fengqin Dong; Wei Guo; Jian Ang; Henry Peng; Z Sheng Guo; David L Bartlett; Stephen G Swisher; Bingliang Fang
Journal:  Cancer Biol Ther       Date:  2007-08-12       Impact factor: 4.742

10.  Presence of antibodies to SSB/La is associated with decreased phagocytic efficiency of neutrophils in patients with systemic lupus erythematosus.

Authors:  Debasis Biswas; Amrita Mathias; Rajeshwar Dayal; Amita Aggarwal; Ramnath Misra; Sita Naik
Journal:  Clin Rheumatol       Date:  2007-11-06       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.